Churchill China plc (CHH)
London Exchange · UK · prices in GBX · close of 21 Oct 2026
Key indicators
| Last close | GBX 370.00 |
|---|---|
| 52-week range | 255.70 – 434.03 |
| Return, 1 month / 3 months | +1.4% / −2.7% |
| Return, 1 year / 3 years | +10.5% / −61.6% |
| Trend | Uptrend |
| RSI (14) | 59 |
| Volatility (1 year) | 34.1% |
| Worst drawdown (1 year) | -36.0% |
| Average daily value traded | 6.10M GBX |
| Dividend yield | 0.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Churchill China is a British pottery company based in Stoke-on-Trent that makes ceramic tableware for the hospitality trade and for retail customers. Its main business supplies plates, bowls, cups and other crockery to hotels, restaurants, pubs, caterers and other food-service operators, alongside ranges sold through retailers. The company designs and manufactures much of its ware in its home city, drawing on the region's long pottery tradition, and serves customers in the UK and in overseas markets.
The shares are listed on the London Exchange in UK under the code CHH, and the price on this page is in pence sterling (GBX). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Churchill China plc (CHH) trades on the London Exchange in UK. It last closed at GBX 370.00 on 21 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 1,713 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 10.5% and over the last three months it fell 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 6.9% | ||
| From 52-week high | -11.9% | ||
| Momentum | 56 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -2.7% | ||
| 6-month return | 11.2% | ||
| 12-month return, skipping the last month | 9.0% | ||
| Stability (higher is calmer) | 45 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.0% | ||
| Liquidity | 70 · Fair | Moderate trading activity. | |
| Average daily value traded | 6.10M GBX | ||
| Zero-volume days | 0.0% | ||
| Income | 34 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.1% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +2.8% |
|---|---|
| 1 month | +1.4% |
| 3 months | −2.7% |
| 6 months | +11.2% |
| 1 year | +10.5% |
| 3 years | −61.6% |
| 5 years | −72.6% |
Signals
| 50-day / 200-day average | 366.43 / 346.21 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 15.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 17 Sep 2026 | GBP 0.0700 |
| 30 Apr 2026 | GBP 0.1400 |
| 11 Sep 2025 | GBP 0.0700 |
| 1 May 2025 | GBP 0.2650 |
| 12 Sep 2024 | GBP 0.1150 |
| 16 May 2024 | GBP 0.2500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.